Vapor for lung volume reduction; pros and cons.
Paul ZarogoulidisWolfgang Hohenforst-SchmidtHaidong HuangKonstantinos SapalidisChristoforos KosmidisStavros TryfonAnastasios VagionasKosmas TsakiridisKonstantinos DrevelegasKonstantinos RomanidisLutz FreitagPublished in: Expert review of respiratory medicine (2020)
Vapor ablation is a novel and safe approach in inducing lung volume reduction in emphysema patients. The effects are gradual, and therefore potentially making it safer than other minimally invasive modalities. Pneumonitis and infection are common side effects. Just as in other BLVR techniques, a case by case evaluation is needed to determine the right candidate for BTVA. Further larger studies are needed before BTVA becomes standard of care in treatment of patients with emphysema.
Keyphrases
- minimally invasive
- end stage renal disease
- chronic obstructive pulmonary disease
- ejection fraction
- chronic kidney disease
- healthcare
- newly diagnosed
- lung function
- palliative care
- prognostic factors
- pulmonary fibrosis
- pain management
- air pollution
- radiofrequency ablation
- atrial fibrillation
- robot assisted
- chronic pain
- health insurance